TUDCA treatment to B16F10-bearing WT mice suppressed tumor growth (Supplementary Fig. 9a) and decreased PD-1 expression on CD4 T cells (Supplementary Fig. 9b). This evidence concerns the gene PDCD1 and neoplasm.